Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial
Titel:
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial
Auteur:
Ciaffi, Laura Koulla-Shiro, Sinata Sawadogo, Adrien Bruno Ndour, Cheik Tidiane Eymard-Duvernay, Sabrina Mbouyap, Pretty Rosereine Ayangma, Liliane Zoungrana, Jacques Gueye, Ndeye Fatou Ngom Diallo, Mohamadou Izard, Suzanne Bado, Guillaume Kane, Coumba Toure Aghokeng, Avelin Fobang Peeters, Martine Girard, Pierre Marie Le Moing, Vincent Reynes, Jacques Delaporte, Eric